Seasonal Affective Disorder Market, by Type (Fall & Winter Seasonal Affective Disorder, Spring & Summer Seasonal Affective Disorder, and Others), by Treatment (Light Therapy, Medications, Psychotherapy, Counselling, and Others), by End User (Hospitals, Cl

Seasonal Affective Disorder Market, by Type (Fall & Winter Seasonal Affective Disorder, Spring & Summer Seasonal Affective Disorder, and Others), by Treatment (Light Therapy, Medications, Psychotherapy, Counselling, and Others), by End User (Hospitals, Clinics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Seasonal affective disorder (SAD) is a form of depression that people experience at a particular time of year or during a particular season. The change in the season highly affects the mood and energy levels, and lead to symptoms of depression that have a significant impact on day-to-day life.
Market Dynamics
Rising incidence of seasonal affective disorder (SAD) is expected to drive seasonal affective disorder market growth over the forecast period. For instance, according to an article published by the Hindawi Publishing Corporation-Depression Research and Treatment, in December 2015, reports that the people who lives farthest from the equator in northern latitudes are most susceptible towards SAD, for instance, in the U.S., 1.4% of those who live in Florida and 9.9% living in Alaska experience seasonal affective disorder.
However, side effects of seasonal affective disorder medication such as Bupropion is expected to hinder the market growth. For instance, according to an article published by the National Center for Biotechnology Information (NCBI), in October 2020, reports that the drug Bupropion, which is approved by the U.S. FDA exhibit several side effects such as tachycardia (cardiovascular disease), rhinitis and pharyngitis (respiratory diseases), and others.
Key features of the study:
This report provides in-depth analysis of the global seasonal affective disorder market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global seasonal affective disorder market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., AbbVie, Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Mylan, Inc., Bausch Health, Koninklijke Philips N.V., Bayer AG, Allergan, Bristol-Myers Squibb, and Henry Schein Inc. among others
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global seasonal affective disorder market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global seasonal affective disorder market.
Detailed Segmentation:
Global Seasonal Affective Disorder Market, By Type:
Fall & Winter Seasonal Affective Disorder
Spring & Summer Seasonal Affective Disorder
Others
Global Seasonal Affective Disorder Market, By Treatment:
Light Therapy
Medications
Psychotherapy
Counselling
Others
Global Seasonal Affective Disorder Market, By End User:
Hospitals
Clinics
Research Institutes
Others
Global Seasonal Affective Disorder Market, By Region:
North America
By Type:
Fall & Winter Seasonal Affective Disorder
Spring & Summer Seasonal Affective Disorder
Others
By Treatment:
Light Therapy
Medications
Psychotherapy
Counselling
Others
By End User:
Hospitals
Clinics
Research Institutes
Others
By Country:
U.S.
Canada
Latin America
By Drug Type:
Fall & Winter Seasonal Affective Disorder
Spring & Summer Seasonal Affective Disorder
Others
By Treatment:
Light Therapy
Medications
Psychotherapy
Counselling
Others
By End User:
Hospitals
Clinics
Research Institutes
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Type:
Fall & Winter Seasonal Affective Disorder
Spring & Summer Seasonal Affective Disorder
Others
By Treatment:
Light Therapy
Medications
Psychotherapy
Counselling
Others
By End User:
Hospitals
Clinics
Research Institutes
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Type:
Fall & Winter Seasonal Affective Disorder
Spring & Summer Seasonal Affective Disorder
Others
By Treatment:
Light Therapy
Medications
Psychotherapy
Counselling
Others
By End User:
Hospitals
Clinics
Research Institutes
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Type:
Fall & Winter Seasonal Affective Disorder
Spring & Summer Seasonal Affective Disorder
Others
By Treatment:
Light Therapy
Medications
Psychotherapy
Counselling
Others
By End User:
Hospitals
Clinics
Research Institutes
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type:
Fall & Winter Seasonal Affective Disorder
Spring & Summer Seasonal Affective Disorder
Others
By Treatment:
Light Therapy
Medications
Psychotherapy
Counselling
Others
By End User:
Hospitals
Clinics
Research Institutes
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Pfizer, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
GlaxoSmithKline plc
Johnson & Johnson Services Inc.
Novartis AG
Sanofi
Teva Pharmaceutical Industries Ltd.
Eli Lily and Company
AbbVie Inc.
F. Hoffmann-La Roche AG
Mylan, Inc.
Bausch Health
Koninklijke Philips N.V.
Bayer AG
Allergan
Bristol-Myers Squibb
Henry Schein Inc.
“*” marked represents similar segmentation in other categories in the respective section.